Replies to post #11595 on RespireRx Pharmaceuticals Inc (RSPI)

[DewDiligence]

Re: Zebra's Law

Here it is (reposted from #msg-4890815):

“Small, underfunded biotechs simply cannot afford to
stop development of their lead drug candidate. Even
if they know it is not working, even if they have
something 100 times more powerful in the lab, they
have to press forward. Otherwise they will not be able
to raise more money. So they end up doing trials that
should never be done.” —zebra4o1